Stevenage, United Kingdom

Graeme Michael Robertson



Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006-2009

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Graeme Michael Robertson: Innovating Treatments for Inflammatory Diseases

Introduction: Graeme Michael Robertson is a notable inventor based in Stevenage, GB, known for his significant contributions to the field of medicinal chemistry. With a total of four patents to his name, Robertson is dedicated to developing innovative compounds aimed at treating inflammatory diseases. His work showcases a blend of scientific expertise and a commitment to addressing critical healthcare challenges.

Latest Patents: Among his most recent innovations are two pivotal patents focusing on morpholinyl-urea and morpholin-acetamide derivatives. These patents detail novel compounds designed to combat inflammatory diseases and outline processes for their preparation, as well as formulations that can be utilized therapeutically. The specifics of these compounds, including variables such as R, X, a, b, and Z, highlight the intricacies involved in medicinal chemistry that Robertson skillfully navigates.

Career Highlights: Currently, Graeme Michael Robertson is affiliated with Glaxo Group Limited, a renowned pharmaceutical company known for its research and development of innovative health solutions. His engagement at Glaxo has allowed him to participate in groundbreaking research, contributing to the advancement of treatments that have the potential to enhance patients' quality of life.

Collaborations: Throughout his career, Robertson has collaborated with talented coworkers including Simon Teanby Hodgson and Xiao Qing Lewell. These partnerships have facilitated the exchange of ideas and expertise, fostering an environment where innovation can thrive and leading to the successful development of his acclaimed patents.

Conclusion: Graeme Michael Robertson exemplifies the role of an inventor who is making a difference through science. His dedication to researching and developing new treatments for inflammatory diseases, combined with his collaborative efforts at Glaxo Group Limited, reinforces the importance of innovation in the healthcare sector. As he continues to contribute to this vital field, Robertson’s work remains a beacon of hope for those affected by inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…